Abbott 1

1. Aspirin and Hemocompatibility after LVAD Implantation in Patients with Atherosclerotic Vascular Disease: A Secondary Analysis from the ARIES-HM3 Randomized Clinical Trial
2. Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial
3. First 5-year multicentric clinical trial experience with the HeartMate 3 left ventricular assist system
4. Concomitant Surgical Procedures and Aspirin Avoidance With Left Ventricular Assist Device Therapy
5. Fully magnetically centrifugal left ventricular assist device and long-term outcomes: the ELEVATE registry
6. Impact of Atrial Fibrillation, Diabetes Mellitus, and Obesity on Outcomes With Aspirin Avoidance and Hemocompatibility With a Left Ventricular Assist Device: An Analysis From the ARIES-HM3 Trial
1